<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01554527</url>
  </required_header>
  <id_info>
    <org_study_id>F029661-00</org_study_id>
    <secondary_id>1R01HL105999-01A1</secondary_id>
    <nct_id>NCT01554527</nct_id>
  </id_info>
  <brief_title>Continuous Positive Airway Pressure (CPAP) After Adenotonsillectomy in Children</brief_title>
  <official_title>Sleep-Disordered Breathing and CPAP After Adenotonsillectomy in Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Michigan Technological University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Obstructive sleep-disordered breathing (SDB) affects 2-3% of children and may lead to
      problems with nighttime sleep and daytime behavior, learning, sleepiness, and mood.
      Adenotonsillectomy (AT) is the second most common surgical procedure in children. It is now
      performed more often for suspected SDB than for any other indication. However, recent studies
      indicate that many if not most children still have SDB after AT, and many still have learning
      or behavioral problems associated with SDB. The goals of this study are: (1) to assess the
      extent that behavior, cognition, and sleepiness in children can improve with Continuous
      positive airway pressure (CPAP) treatment after AT, and (2) to identify which patients stand
      to gain most from post-operative assessment and treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obstructive sleep-disordered breathing (SDB) affects at least 2-3% of children and may have
      substantial adverse impact on behavior and cognition. Adenotonsillectomy (AT), the second
      most common surgical procedure in children, is now performed more often for suspected SDB
      than for any other indication. However, recent studies among an increasingly obese population
      now show something alarming: many if not most children still have SDB after AT, and many
      still suffer from residual neurobehavioral morbidity. Furthermore, the investigators'
      ongoing, 12-year, NIH-funded research has shown that standard preoperative polysomnographic
      measures of SDB do not consistently predict post-AT improvement in behavior and cognition.
      This may arise in part because many children after AT still have SDB, and because linear
      relationships between standard SDB measures and neurobehavioral morbidity may not exist. Even
      at subtle levels, SDB may promote significant neurobehavioral morbidity. Some have suggested
      that polysomnography may be more important after AT than before AT. However, in practice few
      children receive polysomnography before AT, and even fewer after AT, when continuous positive
      airway pressure (CPAP) could still provide definitive relief from SDB. Preliminary data from
      our group suggest that CPAP after AT is well-tolerated by most children and may provide
      significant benefit. However, virtually no published evidence exists to address critical
      clinical questions: which children benefit most from CPAP after AT; what role can clinical
      symptoms or polysomnography play in that determination; and what neurobehavioral gains are
      achieved by CPAP after AT?

      The investigators therefore will undertake a highly practical, clinical study with two main
      goals: (1) to assess the extent that behavior, cognition, and sleepiness in children can
      improve with CPAP after AT, and (2) to identify which patients stand to gain most from
      post-operative assessment and treatment. This research will use reversible SDB-related
      neurobehavioral morbidity as the criteria by which to judge the utility of clinical symptoms
      and polysomnography in identification of candidates for CPAP after AT.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">October 29, 2017</completion_date>
  <primary_completion_date type="Actual">October 29, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Behavioral Index After 6 Months of CPAP or No-CPAP</measure>
    <time_frame>assessed as change from baseline to 6 months of CPAP therapy or no-CPAP</time_frame>
    <description>The sum of the T-scores of The Conners' Parent Rating Scales (CPRS-R:L, ADHD index) and the Child Behavior Checklist (CBCL, Attention Deficit/Hyperactivity Problems) are used to construct the primary study outcome measure Behavioral Index. Behavioral index is a T score (adjusted for age and gender) with a range of &quot;&lt;10&quot; to &quot;&gt;90&quot; - where higher scores mean worse behavior and lower scores mean better behavior, so a negative change score represents an improvement in behavior. T-scores with a mean of 50 and SD of 10 are computed.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Cognition as Shown by NIH Toolbox Composite Score</measure>
    <time_frame>assessed as change from baseline to 6 months of CPAP therapy or no-CPAP</time_frame>
    <description>Scores are reported as standardized scores with a mean of 100 and SD of 15. Minimum value 40 and Maximum value 160. Higher scores are better</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Sleepiness as Measured by Epworth Sleepiness Scale</measure>
    <time_frame>assessed as change from baseline to 6 months of CPAP therapy or no-CPAP</time_frame>
    <description>Epworth Sleepiness Scale scores range from 0 to 24 where higher scores mean greater sleepiness.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Sleepiness After AT as Measured by Multiple Sleep Latency Test (MSLT)</measure>
    <time_frame>assessed as change from baseline to 6 months of CPAP therapy or no-CPAP</time_frame>
    <description>Multiple Sleep Latency Test (MSLT) is an objective measure of sleepiness determined by measure of brain waves and other physiological signals over a 30 minute period. This is measured for five 30 minute periods across the day and average latency to sleep for each participant across those times were used to calculate the mean sleep latency. The score is measured in how quickly one would fall asleep, measured in minutes, so a negative number of minutes in the change score means that participants fell asleep more quickly than previously.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Quality of Life as Measured by Peds QL</measure>
    <time_frame>assessed as change from baseline to 6 months of CPAP therapy or no-CPAP</time_frame>
    <description>Peds-QL is a quality of life symptom measurement with a score range of 0 to 100. Higher scores are better quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CPAP Adherence as Measured by Number of Participants Who Used the CPAP Consistently.</measure>
    <time_frame>Starting at 4 months after AT and continuing through 10 months after AT</time_frame>
    <description>CPAP adherence data will be downloaded from CPAP machines. It is defined for this study as using the CPAP machine for at least an average of 4 hours per night during the last 60 days of the assignment.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in Cognition as Measured by Fluid Cognition Scores</measure>
    <time_frame>assessed as change from baseline to 6 months of CPAP therapy or no-CPAP</time_frame>
    <description>Scores are reported as standardized scores with a mean of 100 and SD of 15. Minimum value 40, Maximum value 160. Higher scores are better</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Cognition After AT as Shown by Academic Achievement</measure>
    <time_frame>assessed as change from baseline to 6 months of CPAP therapy or no-CPAP</time_frame>
    <description>Academic achievement mean score is a standardized score with a mean of 100 and SD 15. Minimum value 40 and Maximum value 160. Higher scores are better</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Sleep Apnea, Obstructive</condition>
  <condition>Sleep Apnea Syndromes</condition>
  <condition>Child Behavior Disorders</condition>
  <condition>Attention Deficit Disorder With Hyperactivity</condition>
  <condition>Disorders of Excessive Somnolence</condition>
  <arm_group>
    <arm_group_label>CPAP treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Children randomized to this arm will receive 6 months of CPAP (or BPAP) treatment, beginning at approximately 4 months after AT, in addition to standard of care. For analysis purposes those children who were non-adherent (CPAP use &lt;4 hours per night) vs. adherent (CPAP use at least 4 hours per night) will be analyzed separately.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No CPAP treatment</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Children randomized to this comparison arm will not be treated with CPAP or BPAP, but will be followed for approximately 10 months after AT while receiving standard of care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>CPAP treatment</intervention_name>
    <description>6 months of treatment with PAP (CPAP or BPAP)</description>
    <arm_group_label>CPAP treatment</arm_group_label>
    <other_name>Continuous positive airway pressure device (CPAP)</other_name>
    <other_name>Bi-level positive airway pressure device (BPAP)</other_name>
    <other_name>Positive Airway Pressure device (PAP)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No CPAP treatment</intervention_name>
    <description>Children randomized to the comparison group will receive routine care</description>
    <arm_group_label>No CPAP treatment</arm_group_label>
    <other_name>Comparison group</other_name>
    <other_name>Control group</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Children ages 5-12 years old,

          2. Scheduled for an adenotonsillectomy for treatment of sleep apnea,

          3. Child must provide assent, and

          4. Parent or legal guardian must be able to speak and read English, and agree to the
             study.

        Exclusion Criteria:

          1. No siblings of children already enrolled in the study,

          2. Children who expect to have another surgery (in addition to AT) during the period of
             participation in this study,

          3. Neurological, psychiatric, or medical conditions, or social factors that may affect
             test results, prevent children from returning for required study visits, or interfere
             with the study treatment, or

          4. Certain medications that affect sleepiness or alertness, for example:

               -  Stimulants (such as Ritalin, Adderall, or Concerta),

               -  Sleep aides (such as Melatonin, Ambien, or Ativan), or

               -  Sedating medicines (such as Benadryl, Klonopin, Xanax, or Valerian).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ronald D. Chervin, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Michigan Health System</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>March 1, 2012</study_first_submitted>
  <study_first_submitted_qc>March 14, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 15, 2012</study_first_posted>
  <results_first_submitted>October 26, 2018</results_first_submitted>
  <results_first_submitted_qc>January 10, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">January 14, 2019</results_first_posted>
  <last_update_submitted>January 10, 2019</last_update_submitted>
  <last_update_submitted_qc>January 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Ronald D. Chervin, M.D., M.S.</investigator_full_name>
    <investigator_title>Professor of Neurology</investigator_title>
  </responsible_party>
  <keyword>polysomnography</keyword>
  <keyword>child</keyword>
  <keyword>continuous positive airway pressure</keyword>
  <keyword>tonsillectomy</keyword>
  <keyword>neuropsychological tests</keyword>
  <keyword>cognition</keyword>
  <keyword>sleepiness</keyword>
  <keyword>behavior</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Disorders of Excessive Somnolence</mesh_term>
    <mesh_term>Disease</mesh_term>
    <mesh_term>Sleepiness</mesh_term>
    <mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
    <mesh_term>Mental Disorders</mesh_term>
    <mesh_term>Child Behavior Disorders</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>October 16, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/27/NCT01554527/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Of 120 consented, 105 were randomized to CPAP or control. (Of the 15 who weren't randomized, 8 were lost to follow up; the other withdrew for various reasons)</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Control Group (Surgery Only - no CPAP)</title>
          <description>The participants who were not assigned to CPAP</description>
        </group>
        <group group_id="P2">
          <title>CPAP After Surgery (Adherent)</title>
          <description>Those participants assigned to CPAP who had at least 4 hours of electronically recorded CPAP use per night</description>
        </group>
        <group group_id="P3">
          <title>CPAP After Surgery (Non-adherent)</title>
          <description>Those participants assigned CPAP who did not have at least 4 hours of electronically recorded CPAP use per night.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
                <participants group_id="P2" count="38"/>
                <participants group_id="P3" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Crossed Over to Control</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Had CPAP Titration</title>
              <participants_list>
                <participants group_id="P1" count="0">No control group members received CPAP (definitionally)</participants>
                <participants group_id="P2" count="38"/>
                <participants group_id="P3" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Initiated CPAP Treatment at Home</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="38"/>
                <participants group_id="P3" count="28"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Completed as a Control</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
                <participants group_id="P2" count="38"/>
                <participants group_id="P3" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="8"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Control Group (Surgery Only - no CPAP)</title>
          <description>The participants who were not assigned to CPAP</description>
        </group>
        <group group_id="B2">
          <title>CPAP After Surgery (Adherent)</title>
          <description>Those participants assigned to CPAP who had at least 4 hours of electronically recorded CPAP use per night</description>
        </group>
        <group group_id="B3">
          <title>CPAP After Surgery (Non-adherent)</title>
          <description>Those participants assigned CPAP who did not have at least 4 hours of electronically recorded CPAP use per night.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="34"/>
            <count group_id="B2" value="38"/>
            <count group_id="B3" value="33"/>
            <count group_id="B4" value="105"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="34"/>
                    <count group_id="B2" value="38"/>
                    <count group_id="B3" value="33"/>
                    <count group_id="B4" value="105"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7.9" spread="2.0"/>
                    <measurement group_id="B2" value="8.3" spread="2.2"/>
                    <measurement group_id="B3" value="8.0" spread="2.0"/>
                    <measurement group_id="B4" value="8.1" spread="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="34"/>
                    <count group_id="B2" value="38"/>
                    <count group_id="B3" value="33"/>
                    <count group_id="B4" value="105"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="16"/>
                    <measurement group_id="B4" value="50"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="17"/>
                    <measurement group_id="B4" value="55"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="34"/>
                    <count group_id="B2" value="38"/>
                    <count group_id="B3" value="33"/>
                    <count group_id="B4" value="105"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="36"/>
                    <measurement group_id="B3" value="33"/>
                    <measurement group_id="B4" value="98"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="34"/>
                    <count group_id="B2" value="38"/>
                    <count group_id="B3" value="33"/>
                    <count group_id="B4" value="105"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="19"/>
                    <measurement group_id="B4" value="76"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="34"/>
                    <count group_id="B2" value="38"/>
                    <count group_id="B3" value="33"/>
                    <count group_id="B4" value="105"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="33"/>
                    <measurement group_id="B4" value="105"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Behavioral Index</title>
          <description>Computation of T-scores (mean of 50, SD of 10). Minimum value &lt; 10, maximum value &gt;90, SD=10. Higher scores indicate worse behavior</description>
          <population>Behavioral Index was not available for one control</population>
          <units>units on a scale (T-Score)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="33"/>
                    <count group_id="B2" value="38"/>
                    <count group_id="B3" value="33"/>
                    <count group_id="B4" value="104"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61.6" spread="13.4"/>
                    <measurement group_id="B2" value="56.5" spread="11.3"/>
                    <measurement group_id="B3" value="57.8" spread="11.6"/>
                    <measurement group_id="B4" value="58.5" spread="12.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>NIH Toolbox Age adjusted composite score</title>
          <description>Scores are reported as Standardized scores with a mean of 100, and SD of 15. Minimum value 40, maximum value 160. Higher scores are good</description>
          <population>Subject ages too young for this particular test so their data are not included</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="34"/>
                    <count group_id="B2" value="38"/>
                    <count group_id="B3" value="29"/>
                    <count group_id="B4" value="101"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="95.7" spread="11.9"/>
                    <measurement group_id="B2" value="96.2" spread="12.3"/>
                    <measurement group_id="B3" value="93.9" spread="11.6"/>
                    <measurement group_id="B4" value="95.1" spread="11.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Epworth Sleepiness Scale</title>
          <description>Modified Epworth for children (Melendres et al 2004); 8 questions with each item summed; minimum score 0, maximum score 24. No SD. Higher scores are worse</description>
          <population>Epworth sleepiness scale score missing for one participant</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="34"/>
                    <count group_id="B2" value="37"/>
                    <count group_id="B3" value="33"/>
                    <count group_id="B4" value="104"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7.2" spread="4.6"/>
                    <measurement group_id="B2" value="6.9" spread="3.9"/>
                    <measurement group_id="B3" value="6.4" spread="3.0"/>
                    <measurement group_id="B4" value="6.8" spread="3.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Multiple Sleep Latency Test (MSLT)</title>
          <description>Mean sleep latency of five 30-min nap attempts. Minimum would be 0 and maximum would be 30 (average of all naps). Shorter times indicate higher sleepiness.</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="34"/>
                    <count group_id="B2" value="38"/>
                    <count group_id="B3" value="33"/>
                    <count group_id="B4" value="105"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24.7" spread="6.0"/>
                    <measurement group_id="B2" value="25.9" spread="4.6"/>
                    <measurement group_id="B3" value="24.4" spread="5.4"/>
                    <measurement group_id="B4" value="25.0" spread="5.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Quality of Life</title>
          <description>Quality of Life is measured by the PedsQL on a scale of 0 to 100, with higher scores meaning better quality of life</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="34"/>
                    <count group_id="B2" value="38"/>
                    <count group_id="B3" value="33"/>
                    <count group_id="B4" value="105"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="78.2" spread="13.7"/>
                    <measurement group_id="B2" value="78.7" spread="16"/>
                    <measurement group_id="B3" value="77.3" spread="17.2"/>
                    <measurement group_id="B4" value="78.1" spread="14.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Academic Achievement Score</title>
          <description>Scores are reported as Standardized scores with a mean of 100 and SD of 15. Minimum value 40; Maximum value 160. Higher scores are better</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="34"/>
                    <count group_id="B2" value="38"/>
                    <count group_id="B3" value="33"/>
                    <count group_id="B4" value="105"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="104.1" spread="13.4"/>
                    <measurement group_id="B2" value="107.2" spread="14.6"/>
                    <measurement group_id="B3" value="102.1" spread="10.7"/>
                    <measurement group_id="B4" value="104.6" spread="13.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Fluid Cognition Composite Age Adjusted score</title>
          <description>Scores are reported as Standardized scores with a mean of 100 and SD of 15. Minimum value 40; Maximum value 160; SD = 15; higher scores are better</description>
          <population>Subject age was too young for this particular test, so their data is not included.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="34"/>
                    <count group_id="B2" value="38"/>
                    <count group_id="B3" value="30"/>
                    <count group_id="B4" value="102"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="97.3" spread="13.2"/>
                    <measurement group_id="B2" value="96" spread="14.2"/>
                    <measurement group_id="B3" value="93.9" spread="11.6"/>
                    <measurement group_id="B4" value="95.8" spread="13.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>(Apnea-Hypopnea Index (AHI)</title>
          <units>events/hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="34"/>
                    <count group_id="B2" value="38"/>
                    <count group_id="B3" value="33"/>
                    <count group_id="B4" value="105"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.4" spread="2.0"/>
                    <measurement group_id="B2" value="2.2" spread="1.7"/>
                    <measurement group_id="B3" value="2.1" spread="2.0"/>
                    <measurement group_id="B4" value="2.2" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sleep Related Breathing Disturbances (SBRD) sub-scale of Pediatric Sleep Questionnaire</title>
          <description>The ratio of number of positive responses to the questionnaire divided by the total number of responses. Minimum 0 maximum 1. A ratio of 0.33 or more suggests high risk for sleep-disordered breathing.</description>
          <units>Ratio</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="34"/>
                    <count group_id="B2" value="38"/>
                    <count group_id="B3" value="33"/>
                    <count group_id="B4" value="105"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.36" spread="0.24"/>
                    <measurement group_id="B2" value="0.32" spread="0.21"/>
                    <measurement group_id="B3" value="0.37" spread="0.17"/>
                    <measurement group_id="B4" value="0.35" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Behavioral Index After 6 Months of CPAP or No-CPAP</title>
        <description>The sum of the T-scores of The Conners' Parent Rating Scales (CPRS-R:L, ADHD index) and the Child Behavior Checklist (CBCL, Attention Deficit/Hyperactivity Problems) are used to construct the primary study outcome measure Behavioral Index. Behavioral index is a T score (adjusted for age and gender) with a range of &quot;&lt;10&quot; to &quot;&gt;90&quot; - where higher scores mean worse behavior and lower scores mean better behavior, so a negative change score represents an improvement in behavior. T-scores with a mean of 50 and SD of 10 are computed.</description>
        <time_frame>assessed as change from baseline to 6 months of CPAP therapy or no-CPAP</time_frame>
        <population>Data for two participants in the control group are not available.</population>
        <group_list>
          <group group_id="O1">
            <title>Control Group (Surgery Only - no CPAP)</title>
            <description>The participants who were not assigned to CPAP</description>
          </group>
          <group group_id="O2">
            <title>CPAP After Surgery (Non-adherent)</title>
            <description>Those participants assigned CPAP who did not have at least 4 hours of electronically recorded CPAP use per night over the last 60 days of the 6 month usage period</description>
          </group>
          <group group_id="O3">
            <title>CPAP After Surgery (Adherent)</title>
            <description>Those participants assigned to CPAP who had an average of at least 4 hours of electronically recorded CPAP use per night over the last 60 days of the 6 month usage period</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Behavioral Index After 6 Months of CPAP or No-CPAP</title>
          <description>The sum of the T-scores of The Conners' Parent Rating Scales (CPRS-R:L, ADHD index) and the Child Behavior Checklist (CBCL, Attention Deficit/Hyperactivity Problems) are used to construct the primary study outcome measure Behavioral Index. Behavioral index is a T score (adjusted for age and gender) with a range of &quot;&lt;10&quot; to &quot;&gt;90&quot; - where higher scores mean worse behavior and lower scores mean better behavior, so a negative change score represents an improvement in behavior. T-scores with a mean of 50 and SD of 10 are computed.</description>
          <population>Data for two participants in the control group are not available.</population>
          <units>T score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="25"/>
                <count group_id="O3" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.7" spread="5.8"/>
                    <measurement group_id="O2" value=".9" spread="4.8"/>
                    <measurement group_id="O3" value="-1.2" spread="6.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Intent to treat for controls vs. treatment (adherent/non-adherent)</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.07</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Cognition as Shown by NIH Toolbox Composite Score</title>
        <description>Scores are reported as standardized scores with a mean of 100 and SD of 15. Minimum value 40 and Maximum value 160. Higher scores are better</description>
        <time_frame>assessed as change from baseline to 6 months of CPAP therapy or no-CPAP</time_frame>
        <population>Lower numbers of participants analyzed are shown here because the tool is not appropriate for younger children</population>
        <group_list>
          <group group_id="O1">
            <title>Control Group (Surgery Only - no CPAP)</title>
            <description>The participants who were not assigned to CPAP</description>
          </group>
          <group group_id="O2">
            <title>CPAP After Surgery (Non-adherent)</title>
            <description>Those participants assigned CPAP who did not have at least 4 hours of electronically recorded CPAP use per night over the last 60 days of the 6 month usage period</description>
          </group>
          <group group_id="O3">
            <title>CPAP After Surgery (Adherent)</title>
            <description>Those participants assigned to CPAP who had an average of at least 4 hours of electronically recorded CPAP use per night over the last 60 days of the 6 month usage period</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Cognition as Shown by NIH Toolbox Composite Score</title>
          <description>Scores are reported as standardized scores with a mean of 100 and SD of 15. Minimum value 40 and Maximum value 160. Higher scores are better</description>
          <population>Lower numbers of participants analyzed are shown here because the tool is not appropriate for younger children</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="23"/>
                <count group_id="O3" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.5" spread="9.5"/>
                    <measurement group_id="O2" value="2.8" spread="9.8"/>
                    <measurement group_id="O3" value="3.9" spread="7.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Intent to treat for controls vs. treatment (adherent/non-adherent)</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.34</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Sleepiness as Measured by Epworth Sleepiness Scale</title>
        <description>Epworth Sleepiness Scale scores range from 0 to 24 where higher scores mean greater sleepiness.</description>
        <time_frame>assessed as change from baseline to 6 months of CPAP therapy or no-CPAP</time_frame>
        <population>Data for two participants are not available</population>
        <group_list>
          <group group_id="O1">
            <title>Control Group (Surgery Only - no CPAP)</title>
            <description>The participants who were not assigned to CPAP</description>
          </group>
          <group group_id="O2">
            <title>CPAP After Surgery (Non-adherent)</title>
            <description>Those participants assigned CPAP who did not have at least 4 hours of electronically recorded CPAP use per night over the last 60 days of the 6 month usage period</description>
          </group>
          <group group_id="O3">
            <title>CPAP After Surgery (Adherent)</title>
            <description>Those participants assigned to CPAP who had an average of at least 4 hours of electronically recorded CPAP use per night over the last 60 days of the 6 month usage period</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Sleepiness as Measured by Epworth Sleepiness Scale</title>
          <description>Epworth Sleepiness Scale scores range from 0 to 24 where higher scores mean greater sleepiness.</description>
          <population>Data for two participants are not available</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="25"/>
                <count group_id="O3" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.6" spread="3.7"/>
                    <measurement group_id="O2" value="-1.0" spread="2.2"/>
                    <measurement group_id="O3" value="-1.9" spread="3.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Intent to treat for controls vs. treatment (adherent/non-adherent)</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.93</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Sleepiness After AT as Measured by Multiple Sleep Latency Test (MSLT)</title>
        <description>Multiple Sleep Latency Test (MSLT) is an objective measure of sleepiness determined by measure of brain waves and other physiological signals over a 30 minute period. This is measured for five 30 minute periods across the day and average latency to sleep for each participant across those times were used to calculate the mean sleep latency. The score is measured in how quickly one would fall asleep, measured in minutes, so a negative number of minutes in the change score means that participants fell asleep more quickly than previously.</description>
        <time_frame>assessed as change from baseline to 6 months of CPAP therapy or no-CPAP</time_frame>
        <population>Data for one participant are not available</population>
        <group_list>
          <group group_id="O1">
            <title>Control Group (Surgery Only - no CPAP)</title>
            <description>The participants who were not assigned to CPAP</description>
          </group>
          <group group_id="O2">
            <title>CPAP After Surgery (Non-adherent)</title>
            <description>Those participants assigned CPAP who did not have at least 4 hours of electronically recorded CPAP use per night over the last 60 days of the 6 month usage period</description>
          </group>
          <group group_id="O3">
            <title>CPAP After Surgery (Adherent)</title>
            <description>Those participants assigned to CPAP who had an average of at least 4 hours of electronically recorded CPAP use per night over the last 60 days of the 6 month usage period</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Sleepiness After AT as Measured by Multiple Sleep Latency Test (MSLT)</title>
          <description>Multiple Sleep Latency Test (MSLT) is an objective measure of sleepiness determined by measure of brain waves and other physiological signals over a 30 minute period. This is measured for five 30 minute periods across the day and average latency to sleep for each participant across those times were used to calculate the mean sleep latency. The score is measured in how quickly one would fall asleep, measured in minutes, so a negative number of minutes in the change score means that participants fell asleep more quickly than previously.</description>
          <population>Data for one participant are not available</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="25"/>
                <count group_id="O3" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.8" spread="4"/>
                    <measurement group_id="O2" value="-1.3" spread="5.1"/>
                    <measurement group_id="O3" value="-1.1" spread="4.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Intent to treat for controls vs. treatment (adherent/non-adherent)</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.5</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Quality of Life as Measured by Peds QL</title>
        <description>Peds-QL is a quality of life symptom measurement with a score range of 0 to 100. Higher scores are better quality of life</description>
        <time_frame>assessed as change from baseline to 6 months of CPAP therapy or no-CPAP</time_frame>
        <population>Data for one participant is not available</population>
        <group_list>
          <group group_id="O1">
            <title>Control Group (Surgery Only - no CPAP)</title>
            <description>The participants who were not assigned to CPAP</description>
          </group>
          <group group_id="O2">
            <title>CPAP After Surgery (Non-adherent)</title>
            <description>Those participants assigned CPAP who did not have at least 4 hours of electronically recorded CPAP use per night over the last 60 days of the 6 month usage period</description>
          </group>
          <group group_id="O3">
            <title>CPAP After Surgery (Adherent)</title>
            <description>Those participants assigned to CPAP who had an average of at least 4 hours of electronically recorded CPAP use per night over the last 60 days of the 6 month usage period</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Quality of Life as Measured by Peds QL</title>
          <description>Peds-QL is a quality of life symptom measurement with a score range of 0 to 100. Higher scores are better quality of life</description>
          <population>Data for one participant is not available</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="25"/>
                <count group_id="O3" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.1" spread="9.0"/>
                    <measurement group_id="O2" value="0.5" spread="10.2"/>
                    <measurement group_id="O3" value="2.4" spread="12.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Intent to treat for controls vs. treatment (adherent/non-adherent)</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.25</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>CPAP Adherence as Measured by Number of Participants Who Used the CPAP Consistently.</title>
        <description>CPAP adherence data will be downloaded from CPAP machines. It is defined for this study as using the CPAP machine for at least an average of 4 hours per night during the last 60 days of the assignment.</description>
        <time_frame>Starting at 4 months after AT and continuing through 10 months after AT</time_frame>
        <group_list>
          <group group_id="O1">
            <title>CPAP Group</title>
            <description>Participants who were assigned to CPAP use.</description>
          </group>
        </group_list>
        <measure>
          <title>CPAP Adherence as Measured by Number of Participants Who Used the CPAP Consistently.</title>
          <description>CPAP adherence data will be downloaded from CPAP machines. It is defined for this study as using the CPAP machine for at least an average of 4 hours per night during the last 60 days of the assignment.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="71"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Change in Cognition as Measured by Fluid Cognition Scores</title>
        <description>Scores are reported as standardized scores with a mean of 100 and SD of 15. Minimum value 40, Maximum value 160. Higher scores are better</description>
        <time_frame>assessed as change from baseline to 6 months of CPAP therapy or no-CPAP</time_frame>
        <population>Lower numbers are shown here as the tool is not appropriate for younger children</population>
        <group_list>
          <group group_id="O1">
            <title>Control Group (Surgery Only - no CPAP)</title>
            <description>The participants who were not assigned to CPAP</description>
          </group>
          <group group_id="O2">
            <title>CPAP After Surgery (Non-adherent)</title>
            <description>Those participants assigned CPAP who did not have at least 4 hours of electronically recorded CPAP use per night over the last 60 days of the 6 month usage period</description>
          </group>
          <group group_id="O3">
            <title>CPAP After Surgery (Adherent)</title>
            <description>Those participants assigned to CPAP who had an average of at least 4 hours of electronically recorded CPAP use per night over the last 60 days of the 6 month usage period</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Cognition as Measured by Fluid Cognition Scores</title>
          <description>Scores are reported as standardized scores with a mean of 100 and SD of 15. Minimum value 40, Maximum value 160. Higher scores are better</description>
          <population>Lower numbers are shown here as the tool is not appropriate for younger children</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="23"/>
                <count group_id="O3" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.7" spread="12.4"/>
                    <measurement group_id="O2" value="1.7" spread="11.5"/>
                    <measurement group_id="O3" value="3.4" spread="10.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Change in Cognition After AT as Shown by Academic Achievement</title>
        <description>Academic achievement mean score is a standardized score with a mean of 100 and SD 15. Minimum value 40 and Maximum value 160. Higher scores are better</description>
        <time_frame>assessed as change from baseline to 6 months of CPAP therapy or no-CPAP</time_frame>
        <population>Data from two participants are not available</population>
        <group_list>
          <group group_id="O1">
            <title>Control Group (Surgery Only - no CPAP)</title>
            <description>The participants who were not assigned to CPAP</description>
          </group>
          <group group_id="O2">
            <title>CPAP After Surgery (Non-adherent)</title>
            <description>Those participants assigned CPAP who did not have at least 4 hours of electronically recorded CPAP use per night over the last 60 days of the 6 month usage period</description>
          </group>
          <group group_id="O3">
            <title>CPAP After Surgery (Adherent)</title>
            <description>Those participants assigned to CPAP who had an average of at least 4 hours of electronically recorded CPAP use per night over the last 60 days of the 6 month usage period</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Cognition After AT as Shown by Academic Achievement</title>
          <description>Academic achievement mean score is a standardized score with a mean of 100 and SD 15. Minimum value 40 and Maximum value 160. Higher scores are better</description>
          <population>Data from two participants are not available</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="25"/>
                <count group_id="O3" value="37"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.0" spread="5.6"/>
                    <measurement group_id="O2" value="1.1" spread="4.7"/>
                    <measurement group_id="O3" value="-2.5" spread="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were followed from consent (which could be before surgery or after surgery) until 10 months after surgery equating to six months after assignment.</time_frame>
      <desc>Based on the adverse event collection structure, it bears noting that some reported AEs may have happened prior to assignment to CPAP or no CPAP use, to participants who ended up reaching baseline visit (4 months after surgery). Since both adherent and non-adherent CPAP participants received CPAP with minimum 1 night of CPAP, these 2 groups were combined for the purposes of AE reporting in order to determine whether any CPAP exposure vs control group (no CPAP) had a different proportion of AE's.</desc>
      <group_list>
        <group group_id="E1">
          <title>CPAP Treatment Group on CPAP</title>
          <description>Children randomized to this arm were assigned and began up to 6 months of CPAP treatment, beginning at approximately 4 months after AT, in addition to standard of care. This arm shows AEs that happened to participants randomized to CPAP but who didn't cross over to the No CPAP group prior to sleep lab. (n=69; original n=71 minus n=2 who crossed over to no-CPAP group). Since both adherent and non-adherent CPAP participants received CPAP and had at minimum one night of CPAP exposure, these two groups were combined for the purposes of AE reporting in order to determine whether any CPAP exposure vs control group (no CPAP) had a different proportion of AE's.</description>
        </group>
        <group group_id="E2">
          <title>No CPAP Treatment Group</title>
          <description>Children shown in this comparison arm were randomized to NO CPAP or were crossed over to No CPAP prior to any CPAP use or CPAP trial in sleep lab.) (N = 36, original 34 plus two crossed over from those randomized to CPAP)</description>
        </group>
        <group group_id="E3">
          <title>Non-randomized Participants</title>
          <description>Participants who were consented but withdrew prior to randomization (n = 15)</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="69"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="69"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="36"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>ER admission due to panic attack</sub_title>
                <description>This occurred after signing consent but prior to randomization</description>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="69"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Hospitalization for ashthma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="69"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Post-operative hospitalization</sub_title>
                <description>Pre-scheduled hospitalizations or within 48 hours of surgery (prior to randomization in the trial)</description>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="69"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="36"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="59" subjects_at_risk="69"/>
                <counts group_id="E2" subjects_affected="26" subjects_at_risk="36"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Ear Pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="69"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Pink Eye</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="69"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="36"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="69"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>GI Distress</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="69"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="36"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Stomach Flu</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="69"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="36"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="69"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="36"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Cold Symptoms</sub_title>
                <counts group_id="E1" subjects_affected="38" subjects_at_risk="69"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="36"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Flu-like Symptoms</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="69"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="36"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Allergic Reaction</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="69"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="36"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>HFMD</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="69"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="36"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Strep Throat</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="69"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="36"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Upper Respiratory Infection</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="69"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="36"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Unrelated Accident</sub_title>
                <counts group_id="E1" subjects_affected="22" subjects_at_risk="69"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="36"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="69"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="36"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="69"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="36"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Enuresis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="69"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Asthma Exacerbation</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="69"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="36"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Voice Alteration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="69"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="36"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Molluscum Contagiosum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="69"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="36"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Skin Irritation</sub_title>
                <counts group_id="E1" subjects_affected="42" subjects_at_risk="69"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="36"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Behavior Issues</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="69"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="36"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Life Event or Change</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="69"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="36"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Ronald Chervin</name_or_title>
      <organization>University of Michigan</organization>
      <phone>734-647-9064</phone>
      <email>chervin@med.umich.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

